Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA profiling of matched pair samples of primary breast cancer vs. lung and pleura metastasis

ABSTRACT: RNA profiling of matched pair samples of primary breast cancer vs. lung and pleura metastasis

PROVIDER: PRJNA608129 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA profiling of matched pair samples of primary breast cancer vs. lung and pleura metastasis

Project description:Patient samples were recruited from a series of female patients with metastatic primary breast cancer (PBC) and biopsy-confirmed breast cancer lung or pleural metastasis (BCLPM) at the Department of Thoracic Surgery, Thoraxklinik, Univ. of Heidelberg, Germany. All patients were included who had received lung or pleural metastasis biopsies from 2003 to 2014 and had a prior history of PBC at the Department of Gynaecology and Obstetrics, Univ. Hospital. Formalin-fixed and paraffin-embedded tissue samples were provided by the Tissue Bank at the National Center for Tumor Diseases (NCT, Heidelberg, Germany) in accordance with the regulations of the Tissue Bank and approval of the Ethics Committee at the Medical Faculty of the Univ. of Heidelberg, approval no. S-716/2018.

2020-09-03 | GSE145752 | GEO

Competitive RNA Pair Controls Gastric Cancer Metastasis

Project description:Competitive RNA Pair Controls Gastric Cancer Metastasis

| PRJNA418152 | ENA

Cancer Samples vs. Matched Adjacent Noncancerous Samples

Project description:This SuperSeries is composed of the following subset Series: GSE33335: Expression data from gastric tissues: Cancer Samples vs. Matched Adjacent Noncancerous Samples GSE33428: Copy number variation profiling of gastric tissues: Cancer Samples vs. Matched Adjacent Noncancerous Samples Refer to individual Series

2012-05-22 | E-GEOD-33429 | biostudies-arrayexpress

Matched Pair Cell Line Tumour RNAseq

Project description:In this study we will sequence the transcriptome of Verified Matched Pair Cancer Cell line tumour samples. This will be married up to whole exome and whole genome sequencing data to establish a full catalog of the variations and mutations found.

2013-07-11 | E-ERAD-157 | biostudies-arrayexpress

Gene expression profile of primary ovarian tumors and matched metastasis

Project description:Gene expression profile of primary ovarian tumors and matched metastasis

| PRJNA924335 | ENA

Transcriptome sequencing of triple-matched samples of gastric cancer patients with ovarian metastasis

Project description:Our aim was to decipher the underlying molecular mechanism of synchronous ovarian metastasis of gastric cancer. We hereby conducted transcriptome sequencing of triple-matched samples including normal gastric mucosa, primary gastric cancer and ovarian metastatic tumors from 3 individual patients with the application of Illumina sequencing platform with 150-bp paired-end. Follow-up analyses not only identified differentially expressed genes between different sample sets (a threshold of fold change >2 and adjusted P value <0.05) but also uncovered significantly enriched signaling pathways of individual type. To sum up, our comparative transcriptomic analyses of triple-matched fresh samples stored in liquid nitrogen profiled the molecular expression and revealed functionally enriched pathways underlying the ovarian metastasis of gastric cancer.

2022-06-20 | GSE206329 | GEO

Comparison of matched primary and metastasis 4T1.2 syngeneic mammary tumor model of spontaneous bone metastasis

Project description:Breast cancer metastasis to bone is a critical determinant of long-term survival after treatment of primary tumors. We used a mouse model of spontaneous bone metastasis to determine new molecular mechanisms. Differential transcriptome comparisons of primary and metastatic tumor cells revealed that a substantial set of genes suppressed in bone metastases were highly enriched for promoter elements for the type I interferon (IFN) regulatory factor, Irf7, itself suppressed in mouse and human metastases. The critical function of the Irf7 pathway was demonstrated by restoration of exogenous Irf7 or systemic interferon administration, which significantly reduced bone metastases and prolonged metastasis-free survival. Using mice deficient in the type I receptor (Ifnar1-/-) or mature B, T and NK cell responses (NOD Scid IL-2rÎ³-/- mice), we demonstrated that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells. Metastasis suppression correlated with decreased accumulation of myeloid-derived suppressor cells and increased CD4++, CD8 T cells and NK cells in the peripheral blood and was reversed by depletion of CD8+ cells and NK cells. Clinical importance of our findings was demonstrated as increased primary tumor Irf7 expression predicted prolonged bone and lung metastasis-free survival. Thus we report for the first time, a novel innate immune pathway, intrinsic to breast cancer cells, whose suppression in turn restricts systemic immunosurveillance to enable metastasis. This pathway may constitute a novel therapeutic target for restricting breast cancer metastases. Microarrays were used to profile transcriptional alterations inherent in tumor cells growing in bone when compared to matched primary tumor cells in the 4T1.2 murine mammary tumor model. Primary and metastasized tumor were isolated from the same mouse with 4 independent biological replicates.

2012-07-17 | E-GEOD-37975 | biostudies-arrayexpress

Profiling gene expression changes in primary ovarian tumors compared to matched metastasis

Project description:Profiling gene expression changes in primary ovarian tumors compared to matched metastasis

| PRJNA564846 | ENA

Canine pimary osteosarcoma tissues vs. matched lung metastases

Project description:Canine pimary osteosarcoma tissues vs. matched lung metastases

| PRJNA484630 | ENA

Transcriptome sequencing of triple-matched samples of gastric cancer patients with ovarian metastasis

Project description:Transcriptome sequencing of triple-matched samples of gastric cancer patients with ovarian metastasis

| PRJNA850175 | ENA